Міжнародне товариство дитячого та підліткового діабету (ISPAD) Узгоджене керівництво з основних принципів лікування діабету у дітей і підлітків 2009 р.
DOI:
https://doi.org/10.24026/1818-1384.3(32).2010.96493Анотація
продовження, початок див. у No 1(30) 2010
Науковий переклад — Н.Б. Зелінська Переклад на українську — О.Я. Гирявенко
Ragnar Hanas, Kim Donaghue, Georgeanna Klingensmith, Peter G.F. Swift – редактори Узгодженого керівництва ISPAD з основних принципів лікування діабету у дітей і підлітків
Посилання
AMERICAN DIABETES ASSOCIATION. Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 2005: 28: S37–S42. https://doi.org/10.2337/diacare.28.suppl_1.s37
WORLD HEALTH ORGANIZATION. Definition, Diagnosis and Classification of Diabetes Mellitus and its Complications. Part 1: Diagnosis and Classification of Diabetes Mellitus. Geneva: WHO/NCD/NCS/99.2, 1999.
RASILAINEN S, YLIPAASTO P, ROIVAINEN M et al. Mechanisms of beta cell death during restricted and unrestricted enterovirus infection. J Med Virol 2004: 72:451–461. https://doi.org/10.1002/jmv.20003
DAHLQUIST GG, FORSBERG J, HAGENFELDT L, BOMAN J, JUTO P. Increased prevalence of enteroviral RNA in blood spots from newborn children who later developed type 1 diabetes: a population-based case-control study. Diabetes Care 2004 27: 285–286. https://doi.org/10.2337/diacare.27.1.285
HARRIS R, DONAHUE K, RATHORE SS, FRAME P, WOOLF SH, LOHR KN. Screening adults for type 2 diabetes: a review of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med 2003: 138: 215–229. https://doi.org/10.7326/0003-4819-138-3-200302040-00015
HOERGER TJ, HARRIS R, HICKS KA, DONAHUE K, SORENSEN S, ENGELGAU M. Screening for type 2 diabetes mellitus: a cost-effectiveness analysis. Ann Intern Med 2004: 140: 689–699. https://doi.org/10.7326/0003-4819-140-9-200405040-00008
GEPTS W. Pathologic anatomy of the pancreas in juvenile diabetes mellitus. Diabetes 1965: 14: 619–633. https://doi.org/10.2337/diab.14.10.619
SABBAH E, SAVOLA K, EBELING T et al. Genetic, autoimmune, and clinical characteristics of childhood- and adult-onset type 1 diabetes. Diabetes Care 2000: 23:1326–1332. https://doi.org/10.2337/diacare.23.9.1326
VERGE CF, STENGER D, BONIFACIO E et al. Combined use of autoantibodies (IA-2 autoantibody, GAD autoantibody, insulin autoantibody, cytoplasmic islet cell antibodies) in type 1 diabetes: Combinatorial Islet Autoantibody Workshop. Diabetes 1998: 47: 1857–1866. https://doi.org/10.2337/diabetes.47.12.1857
LAMBERT AP, GILLESPIE KM, THOMSON G et al. Absolute risk of childhood-onset type 1 diabetes defined by human leukocyte antigen class II genotype: a population-based study in the United Kingdom. J Clin Endocrinol Metab 2004: 89: 4037–4043. https://doi.org/10.1210/jc.2003-032084
NOBLE JA, VALDES AM, COOK M, KLITZ W, THOMSON G, ERLICH HA. The role of HLA class II genes in insulindependent diabetes mellitus: molecular analysis of 180 Caucasian, multiplex families. Am J Hum Genet 1996: 59: 1134–1148.
PUGLIESE A, KAWASAKI E, ZELLER M et al. Sequence analysis of the diabetesprotective human leukocyte antigen-DQB1*0602 allele in unaffected, islet cell antibody-positive first degree relatives and in rare patients with type 1 diabetes. J Clin Endocrinol Metab 1999: 84: 1722–1728. https://doi.org/10.1210/jcem.84.5.5684
KULMALA P, SAVOLA K, REIJONEN H et al. Genetic markers, humoral autoimmunity, and prediction of type 1 diabetes in siblings of affected children. Childhood Diabetes in Finland Study Group. Diabetes 2000: 49: 48–58. https://doi.org/10.2337/diabetes.49.1.48
MACLAREN N, LAN M, COUTANT R et al. Only multiple autoantibodies to islet cells (ICA), insulin, GAD65, IA-2 and IA-2beta predict immune-mediated (Type 1) diabetes in relatives. J Autoimmun 1999: 12: 279–287. https://doi.org/10.1006/jaut.1999.0281
SKYLER JS, KRISCHER JP, WOLFSDORF J et al. Effects of oral insulin in relatives of patients with type 1 diabetes: The Diabetes Prevention Trial–Type 1. Diabetes Care 2005: 28: 1068–1076. https://doi.org/10.2337/diacare.28.5.1068
VERGE CF, GIANANI R, KAWASAKI E et al. Prediction of type I diabetes in first-degree relatives using a combination of insulin, GAD, and ICA512bdc/IA-2 autoantibodies. Diabetes 1996: 45: 926–933. https://doi.org/10.2337/diab.45.7.926
DUNGER DB, SPERLING MA, ACERINI CL et al. European Society for Paediatric Endocrinology/Lawson Wilkins Pediatric Endocrine Society consensus statement on
diabetic ketoacidosis in children and adolescents. Pediatrics 2004: 113: e133–e140. https://doi.org/10.1542/peds.113.2.e133
LEVY-MARCHAL C, PATTERSON CC, GREEN A. Geographical variation of presentation at diagnosis of type I diabetes in children: the EURODIAB study. European and Diabetes. Diabetologia 2001: 44(Suppl. 3): B75–B80. https://doi.org/10.1007/pl00002958
VANDEWALLE CL, COECKELBERGHS MI, DE L et al. Epidemiology, clinical aspects, and biology of IDDM patients under age 40 years. Comparison of data from Antwerp with complete ascertainment with data from Belgium with 40% ascertainment. The Belgian Diabetes Registry. Diabetes Care 1997: 20: 1556–1561. https://doi.org/10.2337/diacare.20.10.1556
PINHAS-HAMIEL O, ZEITLER P. The global spread of type 2 diabetes mellitus in children and adolescents. J Pediatr 2005: 146: 693–700. https://doi.org/10.1016/j.jpeds.2004.12.042
KARVONEN M, VIIK-KAJANDER M, MOLTCHANOVA E, LIBMAN I, LAPORTE R, TUOMILEHTO J. Incidence of childhood type 1 diabetes worldwide. Diabetes Mondiale (DiaMond) Project Group. Diabetes Care 2000: 23: 1516–1526. https://doi.org/10.2337/diacare.23.10.1516
INTERNATIONAL DIABETES FEDERATION. Diabetes Atlas. Second Edn, Brussels: IDF 2003.
DORMAN JS, BUNKER CH. HLA-DQ locus of the human leukocyte antigen complex and type 1 diabetes mellitus: a HuGE review. Epidemiol Rev 2000: 22: 218–227. https://doi.org/10.1093/oxfordjournals.epirev.a018034
GILLESPIE KM, BAIN SC, BARNETT AH et al. The rising incidence of childhood type 1 diabetes and reduced contribution of high-risk HLA haplotypes. Lancet 2004: 364: 1699–1700. https://doi.org/10.1016/s0140-6736(04)17357-1
ILONEN J, REIJONEN H, GREEN A et al. Geographical differences within Finland in the frequency of HLA-DQ genotypes associated with type 1 diabetes susceptibility. Eur J Immunogenet 2000: 27: 225–230. https://doi.org/10.1046/j.1365-2370.2000.00223.x
KUKKO M, VIRTANEN SM, TOIVONEN A et al. Geographical variation in risk HLA-DQB1 genotypes for type 1 diabetes and signs of beta-cell autoimmunity in a high incidence country. Diabetes Care 2004: 27: 676–681. https://doi.org/10.2337/diacare.27.3.676
SUGIHARA S, SAKAMAKI T, KONDA S et al. Association of HLA-DR, DQ genotype with different beta-cell functions at IDDM diagnosis in Japanese children. Diabetes 1997: 46: 1893–1897. https://doi.org/10.2337/diab.46.11.1893
OHTSU S, TAKUBO N, KAZAHARI M et al. Slowly progressing form of type 1 diabetes mellitus in children: genetic analysis compared with other forms of diabetes mellitus in Japanese children. Pediatr Diabetes 2005: 6: 221–229. https://doi.org/10.1111/j.1399-543x.2005.00133.x
KARVONEN M, PITKANIEMI M, PITKANIEMI J, KOHTAMAKI K, TAJIMA N, TUOMILEHTO J. Sex difference in the incidence of insulin-dependent diabetes mellitus: an analysis of the recent epidemiological data. World Health Organization DIAMOND Project Group. Diabetes Metab Rev 1997: 13: 275–291. https://doi.org/10.1002/(sici)1099-0895(199712)13:4<275::aid-dmr197>3.0.co;2-v
GALE EA, GILLESPIE KM. Diabetes and gender. Diabetologia 2001: 44: 3–15. https://doi.org/10.1007/s001250051573
CUCCA F, GOY JV, KAWAGUCHI Y et al. A male-female bias in type 1 diabetes and linkage to chromosome Xp in MHC HLA-DR3-positive patients. Nat Genet 1998:19:301–302. https://doi.org/10.1038/995
WEETS I, KAUFMAN L, VAN der AB et al. Seasonality in clinical onset of type 1 diabetes in Belgian patients above the age of 10 is restricted to HLA-DQ2/DQ8-negative males, which explains the male to female excess in incidence. Diabetologia 2004: 47: 614–621. https://doi.org/10.1007/s00125-004-1369-8
EURODIAB ACE STUDY GROUP. Variation and trends in incidence of childhood diabetes in Europe. Lancet 2000: 355: 873–876. https://doi.org/10.1016/s0140-6736(99)07125-1
KARVONEN M, PITKANIEMI J, TUOMILEHTO J. The onset age of type 1 diabetes in Finnish children has become younger. Diabetes Care 1999: 22: 1066–1070. https://doi.org/10.2337/diacare.22.7.1066
ONKAMO P, VAANANEN S, KARVONEN M, TUOMILEHTO J. Worldwide increase in incidence of type I diabetes – the analysis of the data on published incidence trends. Diabetologia 1999: 42: 1395–1403. https://doi.org/10.1007/s001250051309
GREEN A, BRUTTI G, PATTERSON CC et al. Variation and trends in incidence of childhood diabetes in Europe. Lancet 2000: 355: 873–876. https://doi.org/10.1016/s0140-6736(99)07125-1
LEVY-MARCHAL C, PATTERSON C, GREEN A. Variation by age group and seasonality at diagnosis of childhood IDDM in Europe. The EURODIAB ACE Study Group. Diabetologia 1995: 38: 823–830. https://doi.org/10.1007/s001250050359
OLMOS P, A’HERN R,HEATONDAet al. The significance of the concordance rate for type 1 (insulin-dependent) diabetes in identical twins. Diabetologia 1988: 31: 747–750. https://doi.org/10.1007/bf00274777
HARJUTSALO V, PODAR T, TUOMILEHTO J. Cumulative incidence of type 1 diabetes in 10,168 siblings of Finnish young-onset type 1 diabetic patients. Diabetes 2005: 54: 563–569. https://doi.org/10.2337/diabetes.54.2.563
STECK AK, BARRIGA KJ, EMERY LM, FIALLO-SCHARER RV, GOTTLIEB PA, REWERS MJ. Secondary attack rate of type 1 diabetes in Colorado families. Diabetes Care 2005: 28: 296–300. https://doi.org/10.2337/diacare.28.2.296
LORENZEN T, POCIOT F, HOUGAARD P, NERUP J. Long term risk of IDDM in first-degree relatives of patients with IDDM. Diabetologia 1994: 37: 321–327. https://doi.org/10.1007/bf00398061
GILLESPIE KM, GALE EA, BINGLEY PJ. High familial risk and genetic susceptibility in early onset childhood diabetes. Diabetes 2002: 51: 210–214. https://doi.org/10.2337/diabetes.51.1.210
ANON. Familial risk of type I diabetes in European children. The Eurodiab Ace Study Group and The Eurodiab Ace Substudy 2 Study Group. Diabetologia 1998: 41: 1151–1156. https://doi.org/10.1007/s001250051044
DORMAN JS, STEENKISTE AR, O’LEARY LA, MCCARTHY BJ, LORENZEN T, FOLEY TP. Type 1 diabetes in offspring of parents with type 1 diabetes: the tip of an autoimmune iceberg? Pediatr Diabetes 2000: 1: 17–22. https://doi.org/10.1034/j.1399-5448.2000.010104.x
EL HASHIMY M, ANGELICO MC, MARTIN BC, KROLEWSKI AS, WARRAM JH. Factors modifying the risk of IDDM in offspring of an IDDM parent. Diabetes 1995: 44: 295–299. https://doi.org/10.2337/diab.44.3.295
LORENZEN T, POCIOT F, STILGREN L et al. Predictors of IDDM recurrence risk in offspring of Danish IDDM patients. Danish IDDM Epidemiology and Genetics Group. Diabetologia 1998: 41: 666–673. https://doi.org/10.1007/s001250050966
WARRAM JH, KROLEWSKI AS, GOTTLIEB MS, KAHN CR. Differences in risk of insulin-dependent diabetes in offspring of diabetic mothers and diabetic fathers. N Engl J Med 1984: 311: 149–152. https://doi.org/10.1056/nejm198407193110304
SILVERSTEIN J, KLINGENSMITH G, COPELAND K et al. Care of children and adolescents with type 1 diabetes: a statement of the American Diabetes Association. Diabetes Care 2005: 28: 186–212. https://doi.org/10.2337/diacare.28.1.186
AMERICAN DIABETES ASSOCIATION. Type 2 diabetes in children and adolescents. Pediatrics 2000: 105: 671–680. https://doi.org/10.1542/peds.105.3.671
FAJANS SS, BELL GI, POLONSKY KS. Molecular mechanisms and clinical pathophysiology of maturity-onset diabetes of the young. N Engl J Med 2001: 345: 971–980. https://doi.org/10.1056/nejmra002168
OWEN K, HATTERSLEY AT. Maturity-onset diabetes of the young: from clinical description to molecular genetic characterization. Best Pract Res Clin Endocrinol Metab 2001: 15: 309–323. https://doi.org/10.1053/beem.2001.0148
AMERICAN DIABETES ASSOCIATION. Type 2 diabetes in children and adolescents. American Diabetes Association. Diabetes Care 2000: 23: 381–389. https://doi.org/10.2337/diacare.23.3.381
EHTISHAM S, HATTERSLEY AT, DUNGER DB, BARRETT TG. First UK survey of paediatric type 2 diabetes and MODY. Arch Dis Child 2004: 89: 526–529. https://doi.org/10.1136/adc.2003.027821
VON MUHLENDAHL KE, HERKENHOFF H. Long-term course of neonatal diabetes. N Engl J Med 1995: 333: 704–708. https://doi.org/10.1056/nejm199509143331105
METZ C, CAVE H, BERTRAND AM et al. Neonatal diabetes mellitus: chromosomal analysis in transient and permanent cases. J Pediatr 2002: 141: 483–489. https://doi.org/10.1067/mpd.2002.127089
HERMANN R, LAINE AP, JOHANSSON C et al. Transient but not permanent neonatal diabetes mellitus is associated with paternal uniparental isodisomy of chromosome 6. Pediatrics 2000: 105: 49–52. https://doi.org/10.1542/peds.105.1.49
GLOYN AL, PEARSON ER, ANTCLIFF JF et al. Activating mutations in the gene encoding the ATP-sensitive potassium-channel subunit Kir6.2 and permanent neonatal diabetes. N Engl J Med 2004: 350: 1838–1849. https://doi.org/10.1056/nejmoa032922
MASSA O, IAFUSCO D, D’AMATO E et al. KCNJ11 activating mutations in Italian patients with permanent neonatal diabetes. Hum Mutat 2005: 25: 22–27. https://doi.org/10.1002/humu.20124
NJOLSTAD PR, SOVIK O, CUESTA-MUNOZ A et al. Neonatal diabetes mellitus due to complete glucokinase deficiency. N Engl J Med 2001: 344: 1588–1592. https://doi.org/10.1056/nejm200105243442104
BENNETT CL, CHRISTIE J, RAMSDELL F et al. The immune dysregulation, polyendocrinopathy, enteropathy, Xlinked syndrome (IPEX) is caused by mutations of FOXP3. Nat Genet 2001: 27: 20–21. https://doi.org/10.1038/83713
VAN DEN OUWELAND JM, LEMKES HH, RUITENBEEK W et al. Mutation in mitochondrial tRNA(Leu)(UUR) gene in a large pedigree with maternally transmitted type II diabetes mellitus and deafness. Nat Genet 1992: 1: 368–371. https://doi.org/10.1038/ng0892-368
REARDON W, ROSS RJ, SWEENEY MG et al. Diabetes mellitus associated with a pathogenic point mutation in mitochondrial DNA. Lancet 1992: 340: 1376–1379. https://doi.org/10.1016/0140-6736(92)92560-3
YANKASKAS JR, MARSHALL BC, SUFIAN B, SIMON RH, RODMAN D. Cystic fibrosis adult care: consensus conference report. Chest 2004: 125: 1S–39S. https://doi.org/10.1378/chest.125.1_suppl.1s
MORAN A, HARDIN D, RODMAN D et al. Diagnosis, screening and management of cystic fibrosis related diabetes mellitus: a consensus conference report. Diabetes Res Clin Pract 1999: 45: 61–73. https://doi.org/10.1016/s0168-8227(99)00058-3
DOBSON L, SHELDON CD, HATTERSLEY AT. Conventional measures underestimate glycaemia in cystic fibrosis patients. Diabet Med 2004: 21: 691–696. https://doi.org/10.1111/j.1464-5491.2004.01219.x
DOBSON L, HATTERSLEY AT, TILEY S, ELWORTHY S, OADES PJ, SHELDON CD. Clinical improvement in cystic fibrosis with early insulin treatment. Arch Dis Child 2002: 87: 430–431. https://doi.org/10.1136/adc.87.5.430
NOUSIA-ARVANITAKIS S, GALLI-TSINOPOULOU A, KARAMOUZIS M. Insulin improves clinical status of patients with cystic-fibrosis-related diabetes mellitus. Acta Paediatr 2007: 90: 515–519. https://doi.org/10.1111/j.1651-2227.2001.tb00791.x
PUI CH, BURGHEN GA, BOWMAN WP, AUR RJ. Risk factors for hyperglycemia in children with leukemia receiving L-asparaginase and prednisone. J Pediatr 1981: 99: 46–50. https://doi.org/10.1016/s0022-3476(81)80955-9
DRACHENBERG CB,KLASSEN DK,WEIRMRet al. Islet cell damage associated with tacrolimus and cyclosporine: morphological features in pancreas allograft biopsies and clinical correlation. Transplantation 1999: 68: 396–402. https://doi.org/10.1097/00007890-199908150-00012
MAES BD, KUYPERS D, MESSIAEN T et al. Posttransplantation diabetes mellitus in FK-506-treated renal transplant recipients: analysis of incidence and risk factors. Transplantation 2001: 72: 1655–1661. https://doi.org/10.1097/00007890-200111270-00014
AL UZRI A, STABLEIN DM, COHN A. Posttransplant diabetes mellitus in pediatric renal transplant recipients: a report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS). Transplantation 2001: 72: 1020–1024. https://doi.org/10.1097/00007890-200109270-00007
LEVITT KATZ LE, SWAMI S, ABRAHAM M et al. Neuropsychiatric disorders at the presentation of type 2 diabetes mellitus in children. Pediatr Diabetes 2005: 6: 84–89. https://doi.org/10.1111/j.1399-543x.2005.00105.x
VALERIO G, FRANZESE A, CARLIN E, PECILE P, PERINI R, TENORE A. High prevalence of stress hyperglycaemia in children with febrile seizures and traumatic injuries. Acta Paediatr 2001: 90: 618–622. https://doi.org/10.1080/080352501750258658
SHEHADEH N, ON A, KESSEL I et al. Stress hyperglycemia and the risk for the development of type 1 diabetes. J Pediatr Endocrinol Metab 1997: 10: 283–286. https://doi.org/10.1515/jpem.1997.10.3.283
BHISITKUL DM, VINIK AI, MORROW AL et al. Prediabetic markers in children with stress hyperglycemia. Arch Pediatr Adolesc Med 1996: 150: 936–941. https://doi.org/10.1001/archpedi.1996.02170340050010
VARDI P, SHEHADE N, ETZIONI A et al. Stress hyperglycemia in childhood: a very high risk group for the development of type I diabetes. J Pediatr 1990: 117: 75–77. https://doi.org/10.1016/s0022-3476(05)82447-3
HERSKOWITZ-DUMONT R, WOLFSDORF JI, JACKSON RA, EISENBARTH GS. Distinction between transient hyperglycemia and early insulin-dependent diabetes mellitus in childhood: a prospective study of incidence and prognostic factors. J Pediatr 1993: 123: 347–354. https://doi.org/10.1016/s0022-3476(05)81731-7
SCHATZ DA, KOWA H, WINTER WE, RILEY WJ. Natural history of incidental hyperglycemia and glycosuria of childhood. J Pediatr 1989: 115: 676–680. https://doi.org/10.1016/s0022-3476(89)80641-9
HERSKOWITZ RD, WOLFSDORF JI, RICKER AT et al. Transient hyperglycemia in childhood: identification of a subgroup with imminent diabetes mellitus. Diabetes Res 1988: 9: 161–167.
Incidence and trends of childhood Type 1 diabetes worldwide 1990–1999. Diabet Med 2006: 23: 857–866. https://doi.org/10.1111/j.1464-5491.2006.01925.x
##submission.downloads##
Опубліковано
Номер
Розділ
Ліцензія
Ця робота ліцензується відповідно до Creative Commons Attribution-NonCommercial 4.0 International License.
